Page last updated: 2024-08-17

uridine triphosphate and Arteriosclerosis Obliterans

uridine triphosphate has been researched along with Arteriosclerosis Obliterans in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnstock, G; Giniyatova, LR; Jourjikiya, RK; Khaziakhmetov, DF; Khaziakhmetova, VN; Ziganshin, AU; Ziganshin, BA; Ziganshina, LE	1

Other Studies

1 other study(ies) available for uridine triphosphate and Arteriosclerosis Obliterans

Article	Year
Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein. Vascular pharmacology, 2004, Volume: 42, Issue:1 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Animals; Arteriosclerosis Obliterans; Carbachol; Chronic Disease; Dose-Response Relationship, Drug; Female; Histamine; Humans; Leg; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Saphenous Vein; Uridine Triphosphate; Varicose Veins	2004

Article

Year

Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein.

Vascular pharmacology, 2004, Volume: 42, Issue:1

Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Animals; Arteriosclerosis Obliterans; Carbachol; Chronic Disease; Dose-Response Relationship, Drug; Female; Histamine; Humans; Leg; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Saphenous Vein; Uridine Triphosphate; Varicose Veins

2004